4.2 Article

Utilization of surgical procedures and racial disparity in the treatment of urinary incontinence after prostatectomy

期刊

NEUROUROLOGY AND URODYNAMICS
卷 35, 期 6, 页码 733-737

出版社

WILEY-BLACKWELL
DOI: 10.1002/nau.22790

关键词

artificial urinary sphincter; incontinence; male sling; prostate cancer; racial disparity

向作者/读者索取更多资源

AimsTo analyze the rates of incontinence procedures after radical prostatectomy, and define the variables associated with them. MethodsWe conducted an IRB approved retrospective review of patients with prostate cancer who underwent radical prostatectomy at a single institute from January 1998 to December 2012. Logistic regression and time to event analyses were performed to ascertain variables associated with receipt of incontinence procedure after prostatectomy. ResultsFour thousand four hundred one men underwent radical prostatectomy (69.8% open, 30.1% laparoscopic or robotic) of whom 74.3% were white Caucasian and 22.1% were African-American. Overall, 165 (3.7%) patients underwent a total of 191 procedures for male urethral sling or artificial urinary sphincter placement. African-American men received fewer incontinence procedures than white Caucasian men (2.1% versus 4.3%, P=0.001); and with a longer delay after prostatectomy than white Caucasian men (28.3 months versus 19.9 months, P=0.029). Men who had a laparoscopic or robotic prostatectomy received an incontinence procedure earlier than men who had an open prostatectomy (17.6 months versus 24.4 months, P=0.0001). On multivariate analysis, age at prostatectomy, diagnosis of incontinence, and race were independently associated with receiving an incontinence procedure. ConclusionsThe overall rate of incontinence surgery after radical prostatectomy is low at 3.7%. African-American men receive incontinence procedures at a lower rate and with a longer delay after prostatectomy than white Caucasian men. Further studies are needed to define the reasons for this racial disparity in urinary incontinence surgery in the prostate cancer survivor. Neurourol. Urodynam. 35:733-737, 2016. (c) 2015 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据